Neuromuscular Blocking Agents - Adverse effects
Research News and Information

Monday, November 23, 2009

Perioperative anaphylaxis.

30 Jul 2009 The incidence of immune-mediated anaphylaxis during anesthesia ranges from 1 in 10,000 to 1 in 20,000. Neuromuscular blocking agents represent the most frequently involved substances, followed by latex and antibiotics, but every drug or substance ... Read more...

The pholcodine story.

30 Jul 2009 Anaphylactic reactions to neuromuscular blocking agents during general anesthesia constitute a major cause of concern and a great source of debate among anesthesiologists. The authors' recent investigations, taking the striking differences of ... Read more...

[Muscle relaxants in the ICU]

11 May 2009 Neuromuscular blockade in ICU patients has become less popular, in particular since non-invasive methods of artificial respiration have been introduced. Succinylcholine has numerous side effects. Due to its short onset, Rocuronium may be an ... Read more...

Latest indexed articles for 'Neuromuscular Blocking Agents - Adverse effects'

These are the very latest articles for this heading:

• Anaphylaxis and anesthesia: controversies and new insights. 30 Oct 2009
• Perioperative anaphylaxis. 30 Jul 2009
• The pholcodine story. 30 Jul 2009
• [Muscle relaxants in the ICU] 11 May 2009
• Is the decreasing availability of vecuronium and pancuronium putting patients at risk? 30 Mar 2009
• Tracheal intubation without neuromuscular blocking drugs in children. 27 Feb 2009
• The undesirable effects of neuromuscular blocking drugs. 27 Feb 2009
• Suspected anaphylactic reactions associated with anaesthesia. 30 Jan 2009
• Paralytics in critical care: not always the bad guy. 30 Jan 2009
• Have we learned how to relax our patients, by thinking outside the box? 15 Jan 2009
• [Should breast feeding mothers dispose of their milk after anesthesia?] 30 Dec 2008
• Research, not quality assurance. 30 Dec 2008
• Acute coronary syndrome in cisatracurium-induced anaphylactic shock: Kounis syndrome. 29 Nov 2008
• Residual neuromuscular block and adverse respiratory events. 30 Oct 2008
• Tracheal intubation: optimal conditions, vocal cord damage, and allergy. 29 Sep 2008
• Nerve stimulation in the setting of pharmacologic blockade. 29 Sep 2008
• Skin testing performed in individuals cannot be compared with responses from anaphylactic patients. 29 Sep 2008
• Highlights in nonhymenoptera anaphylaxis. 30 Jul 2008
• Postoperative residual curarization: clinical observation in the post-anesthesia care unit. 29 Jun 2008
• [Use of the muscle relaxant in the intensive care unit] 29 Jun 2008

See a longer list of these articles.

Technical information about 'Neuromuscular Blocking Agents'

Definition: Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.

Registry Number: 0

Descriptor UI: D009466

Alternative terms: Neuromuscular Blocking Agents; Agents, Neuromuscular Blocking; Blocking Agents, Neuromuscular; Neuromuscular Blockers; Blockers, Neuromuscular;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.663.700.710;

Online Note: search CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74

History Note: 75; was see under CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74

Technical Notes: GEN or unspecified; prefer specifics; consider also NEUROMUSCULAR JUNCTION /drug eff